Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Dorelia Lipsa, Ana Ruiz Moreno, Cloé Desmet, Ivana Bianchi, Otmar Geiss, Pascal Colpo & Susanne Bremer-Hoffmann. (2023) Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays. International Journal of Nanomedicine 18, pages 711-720.
Read now
Read now
Anindita De & Young Tag Ko. (2023) A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement. Expert Opinion on Drug Delivery 20:1, pages 75-91.
Read now
Read now
John R. Power, Lucas K. Keyt & Eric D. Adler. (2022) Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations. Expert Review of Cardiovascular Therapy 20:4, pages 241-251.
Read now
Read now
Eder Lilia Romero & Maria Jose Morilla. (2021) Preclinical autophagy modulatory nanomedicines: big challenges, slow advances. Expert Opinion on Drug Delivery 18:10, pages 1415-1434.
Read now
Read now
Mario Di Gioacchino, Claudia Petrarca, Alessia Gatta, Gilda Scarano, Anila Farinelli, Loredana Della Valle, Arianna Lumaca, Pietro Del Biondo, Roberto Paganelli & Luca Di Giampaolo. (2020) Nanoparticle-based immunotherapy: state of the art and future perspectives. Expert Review of Clinical Immunology 16:5, pages 513-525.
Read now
Read now
Articles from other publishers (49)
Mozhgan Keshavarz, Parvin Alizadeh, Firoz Babu Kadumudi, Gorka Orive, Akhilesh K. Gaharwar, Miguel Castilho, Nasim Golafshan & Alireza Dolatshahi-Pirouz. (2023) Multi-leveled Nanosilicate Implants Can Facilitate Near-Perfect Bone Healing. ACS Applied Materials & Interfaces 15:17, pages 21476-21495.
Crossref
Crossref
Meng‐Zhen Yu, Nan‐Nan Wang, Jia‐Qing Zhu & Yao‐Xin Lin. (2023)
The clinical progress and challenges of
mRNA
vaccines
. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, Allie Ivy, Daniel A. Maxenberger, Landon A. Burcham & Christopher E. Nelson. (2023) Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy. Biophysics Reviews 4:1, pages 011307.
Crossref
Crossref
Mariana Colaço, Tiago Roquito, João Panão Costa, Maria Teresa Cruz & Olga Borges. (2023) The Effect of Curcumin-Loaded Glucan Nanoparticles on Immune Cells: Size as a Critical Quality Attribute. Pharmaceutics 15:2, pages 623.
Crossref
Crossref
Tanja Ilić, Jelena B. Đoković, Ines Nikolić, Jelena R. Mitrović, Ivana Pantelić, Snežana D. Savić & Miroslav M. Savić. (2023) Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation. Pharmaceutics 15:2, pages 443.
Crossref
Crossref
Paras Famta, Saurabh Shah, Naitik Jain, Dadi A. Srinivasarao, Aditya Murthy, Tausif Ahmed, Ganesh Vambhurkar, Syed Shahrukh, Shashi Bala Singh & Saurabh Srivastava. (2023) Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics. Journal of Controlled Release 353, pages 166-185.
Crossref
Crossref
Monika Bhattu, Nirmalya Pal, Shikha Kapil, Deepika Kathuria & Meenakshi Verma. 2023. Nanotechnology for Drug Delivery and Pharmaceuticals. Nanotechnology for Drug Delivery and Pharmaceuticals
403
422
.
Lei Yang, Liming Gong, Ping Wang, Xinghui Zhao, Feng Zhao, Zhijie Zhang, Yunfei Li & Wei Huang. (2022) Recent Advances in Lipid Nanoparticles for Delivery of mRNA. Pharmaceutics 14:12, pages 2682.
Crossref
Crossref
Brian Youden, Runqing Jiang, Andrew J. Carrier, Mark R. Servos & Xu Zhang. (2022) A Nanomedicine Structure–Activity Framework for Research, Development, and Regulation of Future Cancer Therapies. ACS Nano 16:11, pages 17497-17551.
Crossref
Crossref
Wim H. De Jong, Robert E. Geertsma & Gerrit Borchard. (2022) Regulatory safety evaluation of nanomedical products: key issues to refine. Drug Delivery and Translational Research 12:9, pages 2042-2047.
Crossref
Crossref
Tomasz Deptuch, Karolina Penderecka, Mariusz Kaczmarek, Sara Molenda & Hanna Dams-Kozlowska. (2022) In vivo study of the immune response to bioengineered spider silk spheres. Scientific Reports 12:1.
Crossref
Crossref
Cátia Domingues, Ana Santos, Carmen Alvarez-Lorenzo, Angel Concheiro, Ivana Jarak, Francisco Veiga, Isabel Barbosa, Marília Dourado & Ana Figueiras. (2022) Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 16:7, pages 9994-10041.
Crossref
Crossref
Ramish Riaz, Hira Waqar, Nasir M. Ahmad & Shah Rukh Abbas. (2022) Novel Magnetic Elastic Phase-Change Nanodroplets as Dual Mode Contrast Agent for Ultrasound and Magnetic Resonance Imaging. Polymers 14:14, pages 2915.
Crossref
Crossref
R. R. Remya, Angeline Julius, T. Y. Suman, V. Mohanavel, Alagar Karthick, C. Pazhanimuthu, Antony V. Samrot & M. Muhibbullah. (2022) Role of Nanoparticles in Biodegradation and Their Importance in Environmental and Biomedical Applications. Journal of Nanomaterials 2022, pages 1-15.
Crossref
Crossref
Attya Bhatti, Ayesha Rehman & Peter John. 2022. Biotechnology in Healthcare. Biotechnology in Healthcare
321
342
.
Jeffrey D. Clogston. (2021) The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand. Advanced Drug Delivery Reviews 176, pages 113897.
Crossref
Crossref
Muhammad Nadeem Hafeez, Christian Celia & Vilma Petrikaite. (2021) Challenges towards Targeted Drug Delivery in Cancer Nanomedicines. Processes 9:9, pages 1527.
Crossref
Crossref
B. Halamoda-Kenzaoui, R.J. Vandebriel, A. Howarth, M. Siccardi, C.A.W. David, N.J. Liptrott, M. Santin, S.E. Borgos, S. Bremer-Hoffmann & F. Caputo. (2021) Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation. Journal of Controlled Release 336, pages 192-206.
Crossref
Crossref
Irina Muljajew, Sophie Huschke, Anuradha Ramoji, Zoltán Cseresnyés, Stephanie Hoeppener, Ivo Nischang, Wanling Foo, Jürgen Popp, Marc Thilo Figge, Christine Weber, Michael Bauer, Ulrich S. Schubert & Adrian T. Press. (2021) Stealth Effect of Short Polyoxazolines in Graft Copolymers: Minor Changes of Backbone End Group Determine Liver Cell-Type Specificity. ACS Nano 15:7, pages 12298-12313.
Crossref
Crossref
Irena Vlatkovic. (2021) Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety. Biomedicines 9:5, pages 530.
Crossref
Crossref
Hwan June KangNuozhou ChenBiraja C. DashHenry C. HsiaFrançois Berthiaume. (2021) Self-Assembled Nanomaterials for Chronic Skin Wound Healing. Advances in Wound Care 10:5, pages 221-233.
Crossref
Crossref
Paula M. Cevaal, Abdalla Ali, Ewa Czuba-Wojnilowicz, Jori Symons, Sharon R. Lewin, Christina Cortez-Jugo & Frank Caruso. (2021)
In Vivo
T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
. ACS Nano 15:3, pages 3736-3753.
Crossref
Crossref
Mukaddes Izci, Christy Maksoudian, Bella B. Manshian & Stefaan J. Soenen. (2021) The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chemical Reviews 121:3, pages 1746-1803.
Crossref
Crossref
Md. Habban Akhter, Sarwar Beg, Mohammed Tarique, Arshi Malik, Sarah Afaq, Hani Choudhry & Salman Hosawi. (2021) Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:2, pages 129777.
Crossref
Crossref
Rogério Sá Gaspar, Beatriz Silva-Lima, Fernando Magro, Armando Alcobia, Fernando Leal da Costa & José Feio. (2020) Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision. Frontiers in Medicine 7.
Crossref
Crossref
Amandeep Singh, Kirandeep Kaur, Uttam Kumar Mandal & Raj Kumar Narang. (2020) Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. Current Nanomedicine 10:3, pages 225-247.
Crossref
Crossref
Olga V. Morozova, Anastasia I. Sokolova, Elizaveta R. Pavlova, Elena I. Isaeva, Ekaterina A. Obraztsova, Ekaterina A. Ivleva & Dmitry V. Klinov. (2020) Protein nanoparticles: cellular uptake, intracellular distribution, biodegradation and induction of cytokine gene expression. Nanomedicine: Nanotechnology, Biology and Medicine 30, pages 102293.
Crossref
Crossref
Andrea Zijno, Delia Cavallo, Gabriella Di Felice, Jessica Ponti, Bianca Barletta, Cinzia Butteroni, Silvia Corinti, Barbara De Berardis, Jessica Palamides, Cinzia L. Ursini, Anna M. Fresegna, Aureliano Ciervo, Raffele Maiello & Flavia Barone. (2020) Use of a common European approach for nanomaterials’ testing to support regulation: a case study on titanium and silicon dioxide representative nanomaterials. Journal of Applied Toxicology 40:11, pages 1511-1525.
Crossref
Crossref
Jun Wan, Jian Wang, Min Zhou, Zhanpeng Rao & Xiean Ling. (2020) A cell membrane vehicle co-delivering sorafenib and doxorubicin remodel the tumor microenvironment and enhance immunotherapy by inducing immunogenic cell death in lung cancer cells. Journal of Materials Chemistry B 8:34, pages 7755-7765.
Crossref
Crossref
Christina Giannakou, Margriet V. D. Z. Park, Irene E. M. Bosselaers, Wim H. de Jong, Jan Willem van der Laan, Henk van Loveren, Rob J. Vandebriel & Robert E. Geertsma. (2020) Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls. WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref
Crossref
Yuzhu Wang, Junjie Li, Indhumathy Subramaniyan, Goncalo Dias do Vale, Jaideep Chaudhary, Arnida Anwar, Mary Wight-Carter, Jeffrey G. McDonald, William C. Putnam, Tao Qin, Hongwei Zhang & Ian R. Corbin. (2020) An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study. Toxicology and Applied Pharmacology 400, pages 115037.
Crossref
Crossref
Xiaomin Yang, Marta Bolsa-Ferruz, Laurent Marichal, Erika Porcel, Daniela Salado-Leza, François Lux, Olivier Tillement, Jean-Philippe Renault, Serge Pin, Frank Wien & Sandrine Lacombe. (2020) Human Serum Albumin in the Presence of AGuIX Nanoagents: Structure Stabilisation without Direct Interaction. International Journal of Molecular Sciences 21:13, pages 4673.
Crossref
Crossref
James G. Cronin, Nicholas JonesCatherine A. ThorntonGareth J. S. JenkinsShareen H. DoakMartin J. D. Clift. (2020) Nanomaterials and Innate Immunity: A Perspective of the Current Status in Nanosafety. Chemical Research in Toxicology 33:5, pages 1061-1073.
Crossref
Crossref
Antonio O. Costa, Claure N. Lunardi & Anderson J. Gomes. (2020) Kinetic Evaluation of Anti-tumor Chlorambucil Release from O-stearoyl Mannose PLGA Nanoparticles. Current Nanomedicine 10:1, pages 63-75.
Crossref
Crossref
Ammad Ahmad Farooqi, Marina Pinheiro, Andreia Granja, Fulvia Farabegoli, Salette Reis, Rukset Attar, Uteuliyev Yerzhan Sabitaliyevich, Baojun Xu & Aamir Ahmad. (2020) EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways. Cancers 12:4, pages 951.
Crossref
Crossref
Andi Alijagic, Daniela Gaglio, Elisabetta Napodano, Roberta Russo, Caterina Costa, Oldřich Benada, Olga Kofroňová & Annalisa Pinsino. (2020) Titanium dioxide nanoparticles temporarily influence the sea urchin immunological state suppressing inflammatory-relate gene transcription and boosting antioxidant metabolic activity. Journal of Hazardous Materials 384, pages 121389.
Crossref
Crossref
Eleni Samaridou, James Heyes & Peter Lutwyche. (2020) Lipid nanoparticles for nucleic acid delivery: Current perspectives. Advanced Drug Delivery Reviews 154-155, pages 37-63.
Crossref
Crossref
Katerina Anagnostou, Minas Stylianakis, Sotiris Michaleas & Athanasios Skouras. 2020. Nanomaterials for Clinical Applications. Nanomaterials for Clinical Applications
123
157
.
Juan BuenoJuan Bueno. 2020. Preclinical Evaluation of Antimicrobial Nanodrugs. Preclinical Evaluation of Antimicrobial Nanodrugs
45
59
.
Tong Zhang, Matthew J. Gaffrey, Wei-Jun Qian & Brian D. Thrall. 2020. Interaction of Nanomaterials with the Immune System. Interaction of Nanomaterials with the Immune System
127
148
.
Gary Hannon, Joanne Lysaght, Neill J. Liptrott & Adriele Prina‐Mello. (2019) Immunotoxicity Considerations for Next Generation Cancer Nanomedicines. Advanced Science 6:19, pages 1900133.
Crossref
Crossref
Anne M. DickinsonJessica M. GoddenKateryna LanovykShaheda S. Ahmed. (2019) Assessing the Safety of Nanomedicines: A Mini Review. Applied In Vitro Toxicology 5:3, pages 114-122.
Crossref
Crossref
Blanka Halamoda-Kenzaoui, Simon Baconnier, Thierry Bastogne, Didier Bazile, Patrick Boisseau, Gerrit Borchard, Sven Even Borgos, Luigi Calzolai, Karin Cederbrant, Gabriella Di Felice, Tiziana Di Francesco, Marina A. Dobrovolskaia, Rogério Gaspar, Belén Gracia, Vincent A. Hackley, Lada Leyens, Neill Liptrott, Margriet Park, Anil Patri, Gert Roebben, Matthias Roesslein, René Thürmer, Patricia Urbán, Valérie Zuang & Susanne Bremer-Hoffmann. (2019) Bridging communities in the field of nanomedicine. Regulatory Toxicology and Pharmacology 106, pages 187-196.
Crossref
Crossref
Sabrina Gioria, Fanny Caputo & Dora Mehn. (2019) Nano-enabled medicinal products: time for an international advanced community?. Nanomedicine 14:14, pages 1787-1790.
Crossref
Crossref
Patricia Urbán, Neill J. Liptrott & Susanne Bremer. (2018) Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies. WIREs Nanomedicine and Nanobiotechnology 11:3.
Crossref
Crossref
Bengt Fadeel. (2019) Hide and Seek: Nanomaterial Interactions With the Immune System. Frontiers in Immunology 10.
Crossref
Crossref
Yee Shan Wong, Bertrand Czarny & Subbu S. Venkatraman. (2019) Precision nanomedicine in atherosclerosis therapy: how far are we from reality?. Precision Nanomedicine 2:1, pages 230-244.
Crossref
Crossref
Paramita Basu, Rajesh Vadlapatla, Priyank Kumar & Joshua P. Gray. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
573
615
.
H. Denny Liggitt. 2019. Nanotechnology Characterization Tools for Environment, Health, and Safety. Nanotechnology Characterization Tools for Environment, Health, and Safety
65
102
.